1
|
Vandael E, Magerman K, Coenen S, Goossens H, Catry B. Antibiotic consumption in Belgian acute care hospitals: analysis of the surveillance methodology, consumption evolution 2003 to 2016 and future perspectives. ACTA ACUST UNITED AC 2020; 24. [PMID: 31771707 PMCID: PMC6864973 DOI: 10.2807/1560-7917.es.2019.24.46.1900098] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BackgroundStudies have demonstrated the link between antimicrobial consumption and the development of antimicrobial resistance. Surveillance of antimicrobial consumption is an action point of the European Commission's 'One Health Action Plan Against Antimicrobial Resistance'.AimThis study aims to compare two methodologies for antibiotic consumption surveillance, investigate the 14-year evolution of antibiotic consumption in Belgian acute care hospitals and discuss future perspectives.MethodsWe compared self-reported data (old methodology) and reimbursement data (new methodology) of national antibiotic consumption surveillance in hospitals. Descriptive analyses were performed on the reimbursement data collected per year and per trimester (2003-2016), per hospital and per unit. Antibiotic consumption was compared with European Surveillance of Antimicrobial Consumption Network (ESAC-Net) results.ResultsThe median differences for defined daily doses (DDDs)/1,000 patient days and DDDs/1,000 admissions were 3.09% and 3.94% when comparing the old vs new methodology. Based on reimbursement data, the median antibiotic consumption in 2016 in 102 Belgian acute care hospitals was 577.1 DDDs/1,000 patient days and 3,890.3 DDDs/1,000 admissions with high variation between hospitals (interquartile ranges (IQR): 511.3-655.0 and 3,450.0-4,400.5, respectively), and similar to 2015. Based on DDDs/1,000 patient days, the magnitude of consumption is comparable with the Netherlands, Denmark and Sweden, but is higher when based on DDDs/1,000 admissions.ConclusionAntibiotic consumption in Belgian acute care hospitals has remained overall stable over time. However, the high variation across hospitals should be further investigated. This surveillance data could be used for benchmarking and assessing interventions to improve antibiotic consumption in these hospitals.
Collapse
Affiliation(s)
- Eline Vandael
- Healthcare-associated infections and antimicrobial resistance, Sciensano, Brussels, Belgium
| | - Koen Magerman
- Department of Microbiology, UHasselt, Hasselt, Belgium.,Jessa Hospital, Hasselt, Belgium.,Belgian Antibiotic Policy Coordination Committee (BAPCOC), Brussels, Belgium
| | - Samuel Coenen
- Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.,Belgian Antibiotic Policy Coordination Committee (BAPCOC), Brussels, Belgium
| | - Herman Goossens
- Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.,Belgian Antibiotic Policy Coordination Committee (BAPCOC), Brussels, Belgium
| | - Boudewijn Catry
- Faculty of Medicine, Université libre de Bruxelles (ULB), Brussels, Belgium.,Healthcare-associated infections and antimicrobial resistance, Sciensano, Brussels, Belgium
| |
Collapse
|
2
|
Schweickert B, Feig M, Schneider M, Willrich N, Behnke M, Peña Diaz LA, Gastmeier P, Richter D, Blank HP, Eckmanns T, Abu Sin M. Antibiotic consumption in Germany: first data of a newly implemented web-based tool for local and national surveillance. J Antimicrob Chemother 2019; 73:3505-3515. [PMID: 30239728 DOI: 10.1093/jac/dky345] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/15/2018] [Accepted: 07/31/2018] [Indexed: 12/18/2022] Open
Abstract
Objectives The features of a newly established, web-based surveillance system for hospital antibiotic consumption are described and data on broad-spectrum antibiotic use in German acute care hospitals are presented. Methods The watch- and reserve-group antibiotics, two categories of antibiotics derived from the WHO Essential Medicines List comprising key agents for antimicrobial stewardship, were used as a framework for data analysis. The median antibiotic consumption densities (ACDs; DDD/100 patient days) for the years 2015/16 based on data from 137 acute care hospitals have been calculated for whole facilities, ICUs and medical and surgical departments, stratified by type of care. Results The new web-based system provides real-time surveillance at unit and facility levels, accessible to all relevant stakeholders. User-defined reports are available via an interactive database, various report types support different approaches to analysis, and different complementing quantification measures of antimicrobial consumption are available. Watch- and reserve-group antibiotics accounted for 42% and 2% of total antibiotic use, respectively. Surgical services presented with considerably lower median ACDs of the watch-group antibiotics compared with medical services. Tertiary care hospitals exhibited higher ACDs of the reserve-group antibiotics and carbapenems than primary/secondary care hospitals, while the ACDs of the watch-group antibiotics as a whole did not differ significantly. Comparing the proportional use with other European countries revealed a relatively high use of the watch-group, ranking beyond the 75th percentile. Conclusions Because of its particular features the new web-based surveillance system is a valuable tool for antimicrobial stewardship. The WHO categories of watch- and reserve-group antibiotics proved to be a useful framework for the analysis of hospital antibiotic consumption data.
Collapse
Affiliation(s)
- Birgitta Schweickert
- Department of Nosocomial Infections, Surveillance of Antibiotic Resistance and Antibiotic Consumption, Robert Koch Institute, Seestr. 10, D-13353 Berlin, Germany
| | - Marcel Feig
- Department of Nosocomial Infections, Surveillance of Antibiotic Resistance and Antibiotic Consumption, Robert Koch Institute, Seestr. 10, D-13353 Berlin, Germany
| | - Marc Schneider
- Department of Nosocomial Infections, Surveillance of Antibiotic Resistance and Antibiotic Consumption, Robert Koch Institute, Seestr. 10, D-13353 Berlin, Germany
| | - Niklas Willrich
- Department of Nosocomial Infections, Surveillance of Antibiotic Resistance and Antibiotic Consumption, Robert Koch Institute, Seestr. 10, D-13353 Berlin, Germany
| | - Michael Behnke
- Institute for Hygiene and Environmental Medicine, Charité - University Medicine Berlin, Hindenburgdamm 27, D-12203 Berlin, Germany
| | - Luis Alberto Peña Diaz
- Institute for Hygiene and Environmental Medicine, Charité - University Medicine Berlin, Hindenburgdamm 27, D-12203 Berlin, Germany
| | - Petra Gastmeier
- Institute for Hygiene and Environmental Medicine, Charité - University Medicine Berlin, Hindenburgdamm 27, D-12203 Berlin, Germany
| | - Doreen Richter
- Department of Nosocomial Infections, Surveillance of Antibiotic Resistance and Antibiotic Consumption, Robert Koch Institute, Seestr. 10, D-13353 Berlin, Germany
| | - Hans-Peter Blank
- Department of Nosocomial Infections, Surveillance of Antibiotic Resistance and Antibiotic Consumption, Robert Koch Institute, Seestr. 10, D-13353 Berlin, Germany
| | - Tim Eckmanns
- Department of Nosocomial Infections, Surveillance of Antibiotic Resistance and Antibiotic Consumption, Robert Koch Institute, Seestr. 10, D-13353 Berlin, Germany
| | - Muna Abu Sin
- Department of Nosocomial Infections, Surveillance of Antibiotic Resistance and Antibiotic Consumption, Robert Koch Institute, Seestr. 10, D-13353 Berlin, Germany
| |
Collapse
|